Sign in

CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company

Cytosorbents Corp

Sign in to watch
Ticker
CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980373793
Phone
973-329-8885
Business address
305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
MedaSorb Technologies CORP, GILDER ENTERPRISES INC
  1. 4 Open-market sale Director sold 50,000 shares at $0.23 ($11,690)
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. S-1 Offering Registration Statement
  4. 4 Conversion President and CEO acquired 1,061,354 shares (conversion)
  5. 4 Conversion Director acquired 44,075.48 shares (conversion)
  6. 4 Open-market sale Director sold 100,000 shares at $0.24 ($24,250)
  7. PRE 14A Proxy Proxy Statement (Preliminary)
  8. 4 Open-market sale Director sold 100,000 shares at $0.24 ($24,100)
  9. 4 Open-market sale Director sold 143,787 shares at $0.24 ($34,509)
  10. 4 Open-market sale Director sold 50,000 shares at $0.24 ($11,840)
  11. 4 Open-market sale Director sold 1,240,762 shares at $0.24 ($297,783)
  12. 8-K Event Results of operations · Bylaws or fiscal year change · Shareholder vote results · Other events
  13. 4 Open-market sale Director sold 50,000 shares at $0.23 ($11,405)
  14. 4 Open-market sale Director sold 50,000 shares at $0.23 ($11,275)
  15. 4 Open-market sale Director sold 41,500 shares at $0.23 ($9,358)
  16. 4 Open-market sale Director sold 8,500 shares at $0.23 ($1,920)
  17. 4 Open-market sale Director sold 17,600 shares at $0.24 ($4,224)
  18. 4 Open-market sale Director sold 50,000 shares at $0.23 ($11,430)
  19. 4 Open-market sale Director sold 30,450 shares at $0.24 ($7,308)
  20. 4 Open-market sale Director sold 100,000 shares at $0.24 ($24,000)

Page 34 of 49 · 978 filings